Stay updated on Defactinib and VS-6766 in Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the Defactinib and VS-6766 in Uveal Melanoma Clinical Trial page.

Latest updates to the Defactinib and VS-6766 in Uveal Melanoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe additions and deletions appear to be administrative, updating the page version to v3.4.2 and removing an outdated funding-status notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a government funding notice indicating possible delays and directing users to cc.nih.gov for operations status. Updated the site revision to v3.4.1, replacing v3.4.0.SummaryDifference0.4%

- Check28 days agoChange DetectedThe changes consist of cosmetic UI text updates (Show glossary, capitalization adjustments) and revision/version metadata (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0), which do not modify study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. This is a metadata/version-control change and does not modify the study content or results.SummaryDifference0.1%

- Check63 days agoChange DetectedDifference0.2%

- Check91 days agoChange DetectedPublication section wording updated and revision number changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Defactinib and VS-6766 in Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Defactinib and VS-6766 in Uveal Melanoma Clinical Trial page.